IAMG 2026 – Bangalore

Abstract Submission Guide

Everything you need to know about submitting your work for the 11th Annual Conference of SIAMG and the Indo-US Rare Bridging Summit.

Topics

Rare phenotypes, skeletal dysplasia, dysmorphology, genotype-phenotype correlation, common traits, basic genetics, genetic counseling, immunogenetics, cancer genetics, developmental genetics, prenatal diagnosis, ethical issues, Cardiac genetics, Neuro genetics, mixed bag.

Abstract Categories

Authors must submit abstracts under one of the following categories:

Category 1

Case Reports

  • › Novel syndromes and previously unreported genetic conditions
  • › Novel phenotypes of known genetic disorders
  • › Prenatal, pediatric, and adult genetic presentations
  • › Rare or unusual clinical presentations across all systems
  • › Diagnostic challenges and unique management insights
  • › Cases highlighting ethical, legal, or psychosocial issues

Structure

Introduction/Background · Case Description · Results/Findings · Conclusion

Category 2

Case Series

  • › Phenotype–genotype correlation studies
  • › Clinical cohorts across any genetic subspecialty
  • › Prenatal, pediatric, or adult genetics series
  • › Large-scale or focused observational clinical genetics studies
  • › Studies involving genetic counselling, service delivery, or education

Structure

Introduction/Background · Materials and Methods · Case Description · Results · Conclusion

Category 3

Original Research

Clinical, Molecular & Translational Genetics

  • › Clinical genetics and large-scale cohort studies
  • › Molecular genetics and genomic diagnostics (next- and third-generation sequencing)
  • › Functional genomics and therapeutic approaches in genetic diseases
  • › Laboratory innovations in wet lab and dry lab diagnostics
  • › Bioinformatics, statistical genetics, and AI applications
  • › Translational research bridging laboratory discoveries to clinical care

Structure

Introduction/Background · Materials and Methods · Results · Conclusion

Structure of the Abstract

  • › Choose only one category best related to your work.
  • › Title [should not exceed 200 characters including spaces].
  • › Names of Authors and affiliation, Primary/presenting author. Max 3 institutions per author.
  • › Email Contact of first and presenting authors.
  • › Body: Word document (.doc/.docx); Font: TNR, size 12, single spacing. Word Limit: 300 words.
  • › Send the abstract to the given mail ID.

Tables, images, graphs, URLs are not allowed.

Submission Details

siamg2026blr@gmail.com
Deadline: 30th Oct 2026

Review Process

All submissions will undergo peer review. Selected abstracts will be invited for oral or poster presentations at the conference.

We look forward to your contributions toward advancing medical genetics.

Abstract Categories

Authors must submit abstracts under one of the following categories:

Category Scope / Description
Case Reports Novel syndromes and previously unreported rare conditions; novel phenotypes of known disorders; prenatal, paediatric, and adult presentations; rare or unusual clinical presentations; diagnostic challenges; ethical, legal, and psychosocial aspects
Case Series Phenotype–genotype correlations; clinical cohorts in rare diseases; prenatal/pediatric/adult series; observational studies and registries; genetic counselling, service delivery, or education studies
Original Research Clinical and cohort studies; molecular genetics and genomic diagnostics; functional genomics; translational research; therapeutic innovation; precision medicine
Diagnostics & Genomic Tech Advances in genetic testing; AI/ML in diagnostics; bioinformatics; computational biology; laboratory innovations; biomarkers and screening approaches
Public Health & Policy Rare disease registries; population genetics; epidemiology; health systems research; policy and regulatory science; newborn screening programs
Patient Advocacy & Ethics Advocacy models; patient engagement; ethical, legal, and social implications; equity and access; psychosocial aspects; caregiver burden
Digital Health Telemedicine; digital platforms; AI-driven clinical tools; wearables; real-world data; health tech and startup innovations
Therapeutics Orphan drugs; gene and cell therapies; drug repurposing; clinical trials; regulatory pathways; access to therapies

Structure of the Abstract

Authors must select only one category that best represents their work. The abstract title should not exceed 200 characters including spaces. All authors and their affiliations must be listed, clearly identifying the presenting author, with a maximum of three institutional affiliations per author.

The abstract body should be submitted as a Word document (.doc or .docx), formatted in Times New Roman, font size 12, with single spacing. The word limit is 300 words, excluding the title and author details.

Structure: Case Reports (Intro, Case Desc, Results, Conclusion); Case Series (Intro, Materials/Methods, Case Desc, Results, Conclusion); Research (Intro, Materials/Methods, Results, Conclusion).

Tables, images, graphs, and URLs are not permitted.

Submission Details

Deadline: 30th Oct 2026

Review Process

All abstracts will undergo peer review by the scientific committee. Selected submissions will be invited for either platform (oral) or poster presentations at the summit.

Join us in advancing rare disease research and innovation.